Reactions Weekly

, Volume 1695, Issue 1, pp 279–279 | Cite as


Development of neratinib resistance leading to disease progression: case report
Case report


  1. Hanker AB, et al. An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer. Cancer Discovery 7: 575-585, No. 6, Jun 2017. Available from: URL: - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations